Mandatory statements

Botox®, Prescription Medicine. For the treatment of frown lines and crow’s feet round the eyes Botox® has risks and benefits. Botulinum toxin type A 50, 100, 200 Units. For product information check with your doctor or Consumer Medicine Information on www.medsafe.govt.nz. Allergan, Auckland.

PROFHILO® containing low & high molecular weight hyaluronic acid, is a Class III medical device for the treatment of the face and body for contours redefinition and laxity remodelling where skin laxity is a problem. Profhilo® has risks and benefits. Do not use with treatments such a laser resurfacing or medium deep skin-peeling. Caution in people on blood thinning medicines. Do not inject into inflamed areas or intravenously or intramuscularly. Possible side effects: pain and swelling at injection site. Accelagen Pty.  Ltd. Whanganui. 

 

REJURAN® is a Class Ill Medical Device designed for tissue restoration, reconstruction, and improvement of physical appearance. REJURAN® has both risks and benefits. Consult your medical practitioner to determine if REJURAN® Injectables are right for you. Each injection contains 20mg/ml of stabilised polynucleotides (PN). For product information, refer to your medical practitioner or the supplier's product details. Always follow your medical practitioner's instructions. This medical device must be administered by a trained professional. Unfunded in NZ. Product and treatment costs apply. For further information, including precautions and contraindications, visit www.rejuran.co.nz or contact the distributor, K Bridge Medical Pty Lta, Australia, via email at info@koridge.com.au. Always read the label and follow directions for use. This product is not available for purchase by the general public. MR11537

 

 

EPTQ - e.p.t.q. Lidocaine is a sterile, non-pyrogenic, viscoelastic, colourless, transparent gel composed of cross-linked sodium hyaluronate gel of non-animal origin with 0.3% lidocaine hydrochloride in a physiologic phosphate buffer. e.p.t.q. Lidocaine is an injectable gel (also called a dermal filler) used for the correction of nasolabial folds. e.p.t.q. Lidocaine is produced with hyaluronic acid (HA), the HA of the gel is made from a non-animal source. e.p.t.q. Lidocaine should not be used on patients: with known hypersensitivity to any of its components; presenting with a general infection, inflammatory or infectious cutaneous problems; with history of severe multiple allergies or anaphylactic shock; prone to hypertrophic scars/keloids or streptococcal diseases; in patients presenting with porphyria; under 18 years of age; in pregnancy or lactation; others. See full Instructions for Use before prescribing for full safety information, available from www.xytide.co.nz. Copyright© 2024. Xytide Biotech Pty Ltd. Always read the label and follow the instructions. This medical device must be administered by a Healthcare Professional. New Zealand Sponsor Xytide Biotech NZ Pty Ltd (NZBN 9429049668612) C/O Alliott Ltd, Level 2, 142 Broadway, Newmarket, Auckland 1023 NZ. For more information please phone +61 1800 570036

 

 

RELFYDESS

Relfydess prescription medicine contains 150 units of relabotulinumtoxinA for the treatment of frown lines and crow's feet around the eyes. Relfydess has risks and benefits. Ask your healthcare professional if Relfydess is right for you and to explain the possible side effects. Tell them if any side effects concern you. For details on precautions and side effects, see the Consumer Medicines Information at: www.measate.govt.nz. Unfunded for aesthetic indications. Product and treatment costs apply Galderma Australia PTY LTD NZBN 9429051812249, NZ Distributor: Healthcare

Logistics, Auckland. NZ-REL-2600004. TAPS NP23980. January 2026.